Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.29% |
| 2 | Consumer Discretionary | 17.84% |
| 3 | Financials | 13.34% |
| 4 | Healthcare | 12.27% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
101
DELISTED
NEVRO CORP.
NVRO
| $135M | 0.13% |
1,690,765
+307,980
| +22% | +$25.5M |
|
102
Ameren
AEE
$29.4B
| $135M | 0.13% |
2,211,556
+397,126
| +22% | +$22.8M |
|
|
CQH
103
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $134M | 0.13% |
4,274,977
-995,292
| -19% | -$28.8M |
|
104
Cigna
CI
$73.7B
| $134M | 0.13% |
787,083
-114,858
| -13% | -$19.9M |
|
|
UNVR
105
DELISTED
Univar Solutions Inc.
UNVR
| $133M | 0.13% |
5,087,615
-17,934
| -0.4% | -$495K |
|
106
Chevron
CVX
$396B
| $133M | 0.13% |
1,052,337
+25,509
| +2% | +$3.17M |
|
107
HDFC Bank
HDB
$119B
| $132M | 0.13% |
5,040,424
+381,564
| +8% | +$9.53M |
|
108
NRG Energy
NRG
$23.4B
| $131M | 0.13% |
4,266,734
-404,919
| -9% | -$13.1M |
|
|
CAVM
109
DELISTED
Cavium, Inc.
CAVM
| $131M | 0.13% |
1,510,423
-31,070
| -2% | -$2.49M |
|
110
ServiceNow
NOW
$150B
| $131M | 0.13% |
3,787,220
-509,535
| -12% | -$17.7M |
|
111
CMS Energy
CMS
$21.4B
| $131M | 0.13% |
2,760,367
| – | – |
|
112
Emerson Electric
EMR
$86.6B
| $129M | 0.13% |
1,869,806
+211,716
| +13% | +$14.9M |
|
113
Five Below
FIVE
$13.4B
| $129M | 0.13% |
1,315,219
-251,711
| -16% | -$20.2M |
|
114
Williams Companies
WMB
$90.2B
| $128M | 0.12% |
4,712,192
-152,284
| -3% | -$4.02M |
|
115
Hilton Worldwide
HLT
$72.4B
| $126M | 0.12% |
1,597,868
+30,079
| +2% | +$2.45M |
|
|
SAGE
116
DELISTED
Sage Therapeutics
SAGE
| $126M | 0.12% |
805,361
+14,338
| +2% | +$2.25M |
|
117
Roper Technologies
ROP
$42.2B
| $124M | 0.12% |
448,348
-61,797
| -12% | -$17M |
|
118
Conagra Brands
CAG
$7.72B
| $124M | 0.12% |
3,459,244
+91,196
| +3% | +$3.39M |
|
119
Oneok
OKE
$59.7B
| $123M | 0.12% |
1,764,443
+107,242
| +6% | +$6.9M |
|
120
Starwood Property Trust
STWD
$5.85B
| $123M | 0.12% |
5,675,124
-340,977
| -6% | -$7.34M |
|
121
Edwards Lifesciences
EW
$52B
| $123M | 0.12% |
2,536,947
+810,144
| +47% | +$37.8M |
|
122
JD.com
JD
$38.8B
| $122M | 0.12% |
3,121,613
+1,363,201
| +78% | +$52.6M |
|
123
Fidelity National Information Services
FIS
$21.4B
| $121M | 0.12% |
1,145,042
+265,293
| +30% | +$27M |
|
124
Zimmer Biomet
ZBH
$19.2B
| $121M | 0.12% |
1,118,866
+42,073
| +4% | +$4.58M |
|
125
Mercado Libre
MELI
$99.7B
| $119M | 0.12% |
399,180
-430,206
| -52% | -$136M |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.91B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.